只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-29 2026-07-31 | THC TENET HEALTHCARE CORP | Foo Lisa Y Officer · EVP, Chief Operating Officer | 卖出（S） | 10,000 | US$258.03 | US$258.03万 | 32,053 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-27 2026-07-28 | THC TENET HEALTHCARE CORP | BIERMAN JAMES L Director | 卖出（S） | 5,000 | US$244.96 | US$122.48万 | 31,604 | SEC |
| 2026-07-27 2026-07-28 | THC TENET HEALTHCARE CORP | Arbour Paola M Officer · EVP, Chief Information Officer | 卖出（S） | 10,878 | US$243.90 | US$265.31万 | 18,413 | SEC |
| 2026-07-27 2026-07-28 | THC TENET HEALTHCARE CORP | Lynch Christopher S. Director | 卖出（S） | 3,837 | US$243.44 | US$934,079.28 | 9,568 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-16 2026-07-21 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 213 | US$19.75 | US$4,206.75 | 4,501,882 | SEC |
| 2026-07-16 2026-07-20 | THQ abrdn Healthcare Opportunities Fund | Mahai Chris LaVictoire Director | 买入（P） | 568 | US$18.49 | US$10,502.32 | 568 | SEC |
| 2026-07-16 2026-07-20 | THW abrdn World Healthcare Fund | Mahai Chris LaVictoire Director | 买入（P） | 796 | US$13.20 | US$10,507.20 | 796 | SEC |
| 2026-07-16 2026-07-20 | HQH abrdn Healthcare Investors | Mahai Chris LaVictoire Director | 买入（P） | 501 | US$20.96 | US$10,500.96 | 501 | SEC |
| 2026-07-16 2026-07-20 | CBIO CRESCENT BIOPHARMA, INC. | Fairmount Healthcare Fund II L.P. Director,TenPercentOwner | 买入（P） | 853,450 | US$14.50 | US$1237.5万 | 3,601,316 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-15 2026-07-16 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine Officer · President | 卖出（S） | 177,068 | US$20.83 | US$368.8万 | 922,313 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 279,644 | US$19.81 | US$554.04万 | 1,107,122 | SEC |
| 2026-07-10 2026-07-14 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 18,356 | US$20.65 | US$378,998.17 | 1,088,766 | SEC |
| 2026-07-01 2026-07-01 | ORKA Oruka Therapeutics, Inc. | Fairmount Healthcare Fund II L.P. Director,TenPercentOwner | 卖出（S） | 3,553,410 | US$84.43 | US$3亿 | 1,131,954 | SEC |
| 2026-07-01 2026-07-01 | ORKA Oruka Therapeutics, Inc. | Fairmount Healthcare Co-Invest III L.P. Director,TenPercentOwner | 卖出（S） | 3,553,410 | US$84.43 | US$3亿 | 1,131,954 | SEC |
| 2026-07-01 2026-07-01 | ALHC Alignment Healthcare, Inc. | KONOWIECKI JOSEPH S Director,Officer · EVP, Corporate Affairs | 卖出（S） | 25,000 | US$24.00 | US$600,000.00 | 1,103,816 | SEC |
| 2026-06-30 2026-07-02 | AVAH Aveanna Healthcare Holdings, Inc. | J.H. Whitney Equity Partners VII, LLC TenPercentOwner | 卖出（S） | 2,419,035 | US$8.01 | US$1937.65万 | 10,112,123 | SEC |
| 2026-06-30 2026-07-02 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 2,419,035 | US$8.01 | US$1937.65万 | 10,112,123 | SEC |
| 2026-06-30 2026-07-02 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 525,844 | US$8.01 | US$421.2万 | 1,813,795 | SEC |
| 2026-06-30 2026-07-02 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 55,121 | US$8.01 | US$441,519.21 | 190,130 | SEC |
| 2026-06-30 2026-07-02 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 2,419,035 | US$8.01 | US$1937.65万 | 10,112,123 | SEC |
| 2026-06-30 2026-07-02 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 525,844 | US$8.01 | US$421.2万 | 1,813,795 | SEC |
| 2026-06-30 2026-07-02 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 55,121 | US$8.01 | US$441,519.21 | 190,130 | SEC |
| 2026-06-26 2026-06-29 | AHR American Healthcare REIT, Inc. | PEAY BRIAN Officer · Chief Financial Officer | 卖出（S） | 25,000 | US$50.70 | US$126.75万 | 152,700 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-26 | ALHC Alignment Healthcare, Inc. | KONOWIECKI JOSEPH S Director,Officer · EVP, Corporate Affairs | 卖出（S） | 25,000 | US$23.00 | US$575,000.00 | 1,128,816 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-26 | VMD VIEMED HEALTHCARE, INC. | Frazier William Director,Officer · Chief Medical Officer | 卖出（S） | 10,000 | US$11.72 | US$117,200.00 | 73,214 | SEC |
| 2026-06-24 2026-06-26 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 72,963 | US$8.00 | US$583,704.00 | 2,339,639 | SEC |
| 2026-06-24 2026-06-26 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 7,648 | US$8.00 | US$61,184.00 | 245,251 | SEC |
| 2026-06-24 2026-06-26 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 919,389 | US$8.00 | US$735.51万 | 12,531,158 | SEC |
| 2026-06-24 2026-06-26 | AVAH Aveanna Healthcare Holdings, Inc. | J.H. Whitney Equity Partners VII, LLC TenPercentOwner | 卖出（S） | 919,389 | US$8.00 | US$735.51万 | 12,531,158 | SEC |
| 2026-06-24 2026-06-26 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 919,389 | US$8.00 | US$735.51万 | 12,531,158 | SEC |
| 2026-06-24 2026-06-26 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 7,648 | US$8.00 | US$61,184.00 | 245,251 | SEC |
| 2026-06-24 2026-06-26 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 72,963 | US$8.00 | US$583,704.00 | 2,339,639 | SEC |
| 2026-06-24 2026-06-26 | AHR American Healthcare REIT, Inc. | Foster Mark E. Officer · EVP, GC & Secretary | 卖出（S） | 2,500 | US$48.58 | US$121,450.00 | 52,995 | SEC |
| 2026-06-24 2026-06-26 | VMD VIEMED HEALTHCARE, INC. | Smokoff Timothy Director | 卖出（S） | 3,364 | US$11.50 | US$38,686.00 | 90,518 | SEC |
| 2026-06-24 2026-06-26 | VMD VIEMED HEALTHCARE, INC. | Smokoff Timothy Director | 卖出（S） | 5,000 | US$11.56 | US$57,800.00 | 85,518 | SEC |
| 2026-06-24 2026-06-26 | VMD VIEMED HEALTHCARE, INC. | Smokoff Timothy Director | 卖出（S） | 5,000 | US$11.41 | US$57,050.00 | 75,518 | SEC |
| 2026-06-24 2026-06-26 | VMD VIEMED HEALTHCARE, INC. | Smokoff Timothy Director | 卖出（S） | 1,636 | US$11.48 | US$18,781.28 | 93,882 | SEC |
| 2026-06-24 2026-06-26 | VMD VIEMED HEALTHCARE, INC. | Smokoff Timothy Director | 卖出（S） | 5,000 | US$11.53 | US$57,650.00 | 80,518 | SEC |
| 2026-06-23 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Fairmount Healthcare Fund II L.P. Director | 卖出（S） | 4,684,781 | US$85.31 | US$4亿 | 0 | SEC |
| 2026-06-23 2026-06-23 | HR Healthcare Realty Trust Inc | Callaway Amanda L Officer · SVP & Chief Accounting Officer | 卖出（S） | 25,767 | US$20.37 | US$524,873.79 | 109,954 | SEC |
| 2026-06-22 2026-06-23 | NHC NATIONAL HEALTHCARE CORP | HASSAN EMIL E Director | 卖出（S） | 5,937 | US$200.00 | US$118.74万 | 65,595 | SEC |
| 2026-06-18 2026-06-18 | ALHC Alignment Healthcare, Inc. | KONOWIECKI JOSEPH S Director,Officer · EVP, Corporate Affairs | 卖出（S） | 25,000 | US$22.00 | US$550,000.00 | 1,153,816 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 389,216 | US$0.35 | US$136,225.60 | 4,268,448 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 27,695 | US$0.35 | US$9,693.25 | 303,719 | SEC |
| 2026-06-16 2026-06-18 | NHC NATIONAL HEALTHCARE CORP | HASSAN EMIL E Director | 卖出（S） | 1,563 | US$199.98 | US$312,568.74 | 71,532 | SEC |
| 2026-06-16 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 61,523 | US$24.98 | US$153.68万 | 6,444,637 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 139,686 | US$0.37 | US$51,683.82 | 4,657,664 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 9,939 | US$0.37 | US$3,677.43 | 331,414 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-15 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 6,146 | US$24.89 | US$152,973.94 | 6,383,114 | SEC |
| 2026-06-15 2026-06-17 | AMN AMN HEALTHCARE SERVICES INC | FOLETTA MARK G Director | 卖出（S） | 1,681 | US$31.07 | US$52,228.67 | 19,917 | SEC |
| 2026-06-15 2026-06-17 | AMN AMN HEALTHCARE SERVICES INC | FOLETTA MARK G Director | 卖出（S） | 2,000 | US$31.07 | US$62,140.00 | 17,917 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 120,216 | US$0.39 | US$46,884.24 | 4,797,350 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 8,554 | US$0.39 | US$3,336.06 | 341,353 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-15 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine Officer · President | 卖出（S） | 30,000 | US$19.55 | US$586,500.00 | 947,313 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 159,119 | US$0.40 | US$63,647.60 | 4,917,566 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 11,322 | US$0.40 | US$4,528.80 | 349,907 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-15 | ALHC Alignment Healthcare, Inc. | Kim Hyong Officer · Chief Medical Officer | 卖出（S） | 35,951 | US$19.86 | US$713,986.86 | 331,750 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 19,728,353 | US$20.00 | US$3.95亿 | 26,285,093 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 1,460,397 | US$20.00 | US$2920.79万 | 2,648,278 | SEC |
| 2026-06-11 2026-06-12 | ALHC Alignment Healthcare, Inc. | KONOWIECKI JOSEPH S Director,Officer · EVP, Corporate Affairs | 卖出（S） | 25,000 | US$21.00 | US$525,000.00 | 1,178,816 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 17,437 | US$0.38 | US$6,626.06 | 361,229 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 245,066 | US$0.38 | US$93,125.08 | 5,076,685 | SEC |
| 2026-06-10 2026-06-12 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 74,936 | US$19.65 | US$147.25万 | 1,609,830 | SEC |
| 2026-06-10 2026-06-12 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 223,064 | US$20.60 | US$459.51万 | 1,386,766 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 42,872 | US$0.37 | US$15,862.64 | 5,321,751 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 3,051 | US$0.37 | US$1,128.87 | 378,666 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 345,235 | US$0.37 | US$127,736.95 | 5,364,623 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 24,565 | US$0.37 | US$9,089.05 | 381,717 | SEC |
| 2026-06-03 2026-06-05 | AVAH Aveanna Healthcare Holdings, Inc. | J.H. Whitney Equity Partners VII, LLC TenPercentOwner | 卖出（S） | 5,842,240 | US$6.24 | US$3645.56万 | 13,450,547 | SEC |
| 2026-06-03 2026-06-05 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 1,047,913 | US$6.24 | US$653.9万 | 2,412,602 | SEC |
| 2026-06-03 2026-06-05 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 109,847 | US$6.24 | US$685,445.28 | 252,899 | SEC |
| 2026-06-03 2026-06-05 | AVAH Aveanna Healthcare Holdings, Inc. | WILLIAMS ROBERT M JR TenPercentOwner | 卖出（S） | 5,842,240 | US$6.24 | US$3645.56万 | 13,450,547 | SEC |
| 2026-06-03 2026-06-05 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 109,847 | US$6.24 | US$685,445.28 | 252,899 | SEC |
| 2026-06-03 2026-06-05 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 1,047,913 | US$6.24 | US$653.9万 | 2,412,602 | SEC |
| 2026-06-03 2026-06-05 | AVAH Aveanna Healthcare Holdings, Inc. | VIGANO PAUL R TenPercentOwner | 卖出（S） | 5,842,240 | US$6.24 | US$3645.56万 | 13,450,547 | SEC |
| 2026-06-02 2026-06-02 | ALHC Alignment Healthcare, Inc. | Kent Mark D. Officer · President - MSO | 买入（P） | 14,848 | US$13.31 | US$197,626.88 | 14,848 | SEC |
| 2026-06-01 2026-06-03 | AHR American Healthcare REIT, Inc. | Foster Mark E. Officer · EVP, GC & Secretary | 卖出（S） | 2,000 | US$48.32 | US$96,640.00 | 55,495 | SEC |
| 2026-06-01 2026-06-02 | NHC NATIONAL HEALTHCARE CORP | Piercey Lisa Director | 买入（P） | 949 | US$184.26 | US$174,862.74 | 949 | SEC |
| 2026-05-28 2026-05-29 | THC TENET HEALTHCARE CORP | KERREY J ROBERT Director | 卖出（S） | 361 | US$177.52 | US$64,084.72 | 16,804 | SEC |
| 2026-05-28 2026-05-29 | THC TENET HEALTHCARE CORP | KERREY J ROBERT Director | 卖出（S） | 1,969 | US$173.12 | US$340,873.28 | 20,473 | SEC |
| 2026-05-28 2026-05-29 | THC TENET HEALTHCARE CORP | KERREY J ROBERT Director | 卖出（S） | 1,690 | US$173.97 | US$294,009.30 | 18,783 | SEC |
| 2026-05-28 2026-05-29 | THC TENET HEALTHCARE CORP | KERREY J ROBERT Director | 卖出（S） | 905 | US$176.89 | US$160,085.45 | 17,165 | SEC |
| 2026-05-28 2026-05-29 | THC TENET HEALTHCARE CORP | KERREY J ROBERT Director | 卖出（S） | 713 | US$175.13 | US$124,867.69 | 18,070 | SEC |
| 2026-05-27 2026-05-28 | THC TENET HEALTHCARE CORP | West Nadja Director | 卖出（S） | 3,000 | US$177.35 | US$532,050.00 | 24,805 | SEC |
| 2026-05-27 2026-05-28 | PLYX Polaryx Therapeutics, Inc. | Mstone Partners Healthcare Ltd Director,TenPercentOwner | 买入（P） | 88,453 | US$4.07 | US$360,003.71 | 24,233,249 | SEC |
| 2026-05-22 2026-05-26 | GEHC GE HealthCare Technologies Inc. | Lobo Kevin Director | 买入（P） | 10,000 | US$64.18 | US$641,800.00 | 14,363 | SEC |
| 2026-05-21 2026-05-22 | NHC NATIONAL HEALTHCARE CORP | LAROCHE RICHARD F JR Director | 卖出（S） | 7,500 | US$195.14 | US$146.36万 | 205,760 | SEC |
| 2026-05-20 2026-05-21 | AVAH Aveanna Healthcare Holdings, Inc. | Cunningham Patrick A. Officer · Chief Compliance Officer | 卖出（S） | 125,000 | US$7.59 | US$948,750.00 | 212,755 | SEC |
| 2026-05-20 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 996 | US$24.94 | US$24,840.24 | 6,376,968 | SEC |
| 2026-05-19 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 3,802 | US$24.97 | US$94,935.94 | 6,375,972 | SEC |
| 2026-05-19 2026-05-20 | NHC NATIONAL HEALTHCARE CORP | Shelly Timothy J. Officer · Sr.VP Operations | 卖出（S） | 1,853 | US$197.22 | US$365,448.66 | 1,294 | SEC |
| 2026-05-15 2026-05-19 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine Officer · President | 卖出（S） | 30,000 | US$16.09 | US$482,700.00 | 998,813 | SEC |
| 2026-05-14 2026-05-15 | MOH MOLINA HEALTHCARE, INC. | HEBERT MAURICE Officer · Chief Accounting Officer | 卖出（S） | 600 | US$191.55 | US$114,930.00 | 12,815 | SEC |
| 2026-05-12 2026-05-14 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 6,387 | US$24.90 | US$159,036.30 | 6,372,170 | SEC |
| 2026-05-12 2026-05-13 | GEHC GE HealthCare Technologies Inc. | Hochman Rodney F Director | 买入（P） | 1,618 | US$62.03 | US$100,364.54 | 1,618 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 6,719 | US$0.64 | US$4,300.16 | 406,282 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 94,432 | US$0.64 | US$60,436.48 | 5,709,858 | SEC |
| 2026-05-12 2026-05-12 | SRTS Sensus Healthcare, Inc. | Sachetta Eric Director | 买入（P） | 1,500 | US$3.34 | US$5,010.00 | 143,613 | SEC |
| 2026-05-11 2026-05-13 | VRDN Viridian Therapeutics, Inc.\DE | Fairmount Healthcare Fund II L.P. Director,TenPercentOwner | 买入（P） | 1,176,470 | US$17.00 | US$2000万 | 5,090,928 | SEC |
| 2026-05-11 2026-05-13 | VRDN Viridian Therapeutics, Inc.\DE | Fairmount Healthcare Fund II GP LLC Director,TenPercentOwner | 买入（P） | 1,176,470 | US$17.00 | US$2000万 | 5,090,928 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | MOH MOLINA HEALTHCARE, INC. | Barlow Jeff D. Officer · Chief Legal Officer | 卖出（S） | 17,811 | US$186.12 | US$331.5万 | 67,175 | SEC |
| 2026-05-11 2026-05-13 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 280,893 | US$16.85 | US$473.3万 | 1,525,748 | SEC |
| 2026-05-11 2026-05-13 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 17,107 | US$17.54 | US$300,056.78 | 1,508,641 | SEC |
| 2026-05-11 2026-05-12 | PBH Prestige Consumer Healthcare Inc. | Zerillo Jeffrey Officer · Senior VP Operations | 卖出（S） | 351 | US$52.28 | US$18,350.28 | 41,810 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 5,812 | US$0.67 | US$3,894.04 | 413,001 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 81,678 | US$0.67 | US$54,724.26 | 5,804,290 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 25,720 | US$25.00 | US$643,000.00 | 6,365,783 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 14,149 | US$24.47 | US$346,226.03 | 6,340,063 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 351,514 | US$0.71 | US$249,574.94 | 5,885,968 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 25,012 | US$0.71 | US$17,758.52 | 418,813 | SEC |
| 2026-05-08 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 1,483 | US$24.98 | US$37,045.34 | 6,325,914 | SEC |
| 2026-05-08 2026-05-11 | GEHC GE HealthCare Technologies Inc. | Yang Watkin Phoebe L. Director | 买入（P） | 1,000 | US$63.01 | US$63,010.00 | 13,702 | SEC |
| 2026-05-07 2026-05-11 | PBH Prestige Consumer Healthcare Inc. | Zerillo Jeffrey Officer · Senior VP Operations | 卖出（S） | 305 | US$54.36 | US$16,579.80 | 42,161 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 1,985 | US$24.95 | US$49,525.75 | 6,324,431 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 7,921 | US$24.34 | US$192,797.14 | 6,322,446 | SEC |
| 2026-05-06 2026-05-07 | GEHC GE HealthCare Technologies Inc. | CULP H LAWRENCE JR Director | 买入（P） | 80,805 | US$61.88 | US$500.02万 | 151,207 | SEC |
| 2026-05-06 2026-05-07 | GEHC GE HealthCare Technologies Inc. | Stromberg William J Director | 买入（P） | 1,000 | US$61.69 | US$61,690.00 | 15,330 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 53,407 | US$24.83 | US$132.61万 | 6,314,525 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 14,611 | US$23.77 | US$347,303.47 | 6,261,118 | SEC |
| 2026-05-05 2026-05-07 | PBH Prestige Consumer Healthcare Inc. | Zerillo Jeffrey Officer · Senior VP Operations | 卖出（S） | 1,207 | US$54.99 | US$66,372.93 | 42,820 | SEC |
| 2026-05-05 2026-05-06 | PBH Prestige Consumer Healthcare Inc. | Zerillo Jeffrey Officer · Senior VP Operations | 卖出（S） | 346 | US$55.32 | US$19,140.72 | 44,334 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 10,268 | US$25.00 | US$256,700.00 | 6,246,507 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 87,143 | US$24.59 | US$214.28万 | 6,236,239 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 133,750 | US$18.00 | US$240.75万 | 354,938 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 2,541,250 | US$18.00 | US$4574.25万 | 6,149,096 | SEC |
| 2026-05-01 2026-05-01 | GEHC GE HealthCare Technologies Inc. | SACCARO JAMES Officer · Chief Financial Officer | 买入（P） | 3,310 | US$60.60 | US$200,586.00 | 87,471 | SEC |
| 2026-04-30 2026-04-30 | GEHC GE HealthCare Technologies Inc. | Arduini Peter J Director,Officer · President and CEO | 买入（P） | 4,169 | US$59.93 | US$249,848.17 | 259,424 | SEC |
| 2026-04-30 2026-04-30 | GEHC GE HealthCare Technologies Inc. | Jimenez Frank R Officer · GC & Corporate Secretary | 买入（P） | 1,750 | US$60.45 | US$105,787.50 | 93,932 | SEC |
| 2026-04-28 2026-04-30 | DRUG BRIGHT MINDS BIOSCIENCES INC. | Cormorant Global Healthcare Master Fund, LP Other | 卖出（S） | 109,331 | US$89.50 | US$978.51万 | 950,000 | SEC |
| 2026-04-22 2026-04-24 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 165,150 | US$15.77 | US$260.44万 | 2,402,095 | SEC |
| 2026-04-20 2026-04-21 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 171,963 | US$15.77 | US$271.19万 | 2,567,245 | SEC |
| 2026-04-17 2026-04-21 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 458,411 | US$16.28 | US$746.29万 | 2,739,208 | SEC |
| 2026-04-15 2026-04-15 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 53,644 | US$16.01 | US$858,840.44 | 3,197,619 | SEC |
| 2026-04-15 2026-04-15 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine Officer · President | 卖出（S） | 30,000 | US$20.87 | US$626,100.00 | 1,028,813 | SEC |
| 2026-04-14 2026-04-15 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 153,735 | US$15.97 | US$245.51万 | 3,251,263 | SEC |
| 2026-04-13 2026-04-15 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 530,610 | US$16.15 | US$856.94万 | 3,404,998 | SEC |
| 2026-04-13 2026-04-13 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 82,299 | US$20.80 | US$171.18万 | 1,806,641 | SEC |
| 2026-04-10 2026-04-13 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 201,900 | US$20.58 | US$415.51万 | 1,902,741 | SEC |
| 2026-04-10 2026-04-13 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 13,801 | US$21.38 | US$295,065.38 | 1,888,940 | SEC |
| 2026-04-10 2026-04-10 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 828 | US$15.75 | US$13,041.00 | 3,935,608 | SEC |
| 2026-04-09 2026-04-10 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 135,201 | US$16.59 | US$224.3万 | 3,936,436 | SEC |
| 2026-04-08 2026-04-10 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 130,862 | US$16.91 | US$221.29万 | 4,071,637 | SEC |
| 2026-04-08 2026-04-10 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 353,242 | US$16.32 | US$576.49万 | 4,202,499 | SEC |
| 2026-04-07 2026-04-08 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 117,759 | US$21.40 | US$252万 | 2,104,641 | SEC |
| 2026-04-07 2026-04-08 | ALHC Alignment Healthcare, Inc. | KAO JOHN E Director,Officer · Chief Executive Officer | 卖出（S） | 132,241 | US$20.67 | US$273.34万 | 2,222,400 | SEC |
| 2026-04-07 2026-04-08 | ALHC Alignment Healthcare, Inc. | Head James M Officer · Chief Financial Officer | 卖出（S） | 11,100 | US$21.08 | US$233,988.00 | 173,495 | SEC |
| 2026-04-06 2026-04-06 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 44,728 | US$17.31 | US$774,241.68 | 4,562,516 | SEC |
| 2026-04-06 2026-04-06 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 6,775 | US$18.50 | US$125,337.50 | 4,555,741 | SEC |
| 2026-04-06 2026-04-06 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 537,754 | US$16.51 | US$887.83万 | 4,607,244 | SEC |
| 2026-04-02 2026-04-06 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 1,525 | US$19.06 | US$29,066.50 | 5,144,998 | SEC |
| 2026-04-02 2026-04-06 | VOR Vor Biopharma Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 卖出（S） | 258,475 | US$18.23 | US$471.2万 | 5,146,523 | SEC |
| 2026-04-01 2026-04-01 | ALHC Alignment Healthcare, Inc. | JOYCE CHRISTOPHER J Officer · Chief Legal and Admin. Officer | 卖出（S） | 18,013 | US$17.79 | US$320,451.27 | 305,451 | SEC |
| 2026-03-31 2026-04-01 | ZBIO Zenas BioPharma, Inc. | Fairmount Healthcare Fund II L.P. Director | 买入（P） | 150,000 | US$20.00 | US$300万 | 2,359,025 | SEC |
| 2026-02-20 2026-04-13 | ACET Adicet Bio, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 74,751 | US$7.27 | US$543,439.77 | 1,182,624 | SEC |
| 2026-02-19 2026-04-13 | ACET Adicet Bio, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 74,268 | US$7.21 | US$535,472.28 | 1,107,873 | SEC |
| 2026-02-18 2026-04-13 | ACET Adicet Bio, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 74,577 | US$7.04 | US$525,022.08 | 1,033,605 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| THCH | 462 | 0 | 1,156 | 39.97% | Q |
| THC | 143,898.8974 | 100 | 365,022.1466 | 39.42% | B, Q, N |